Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 USD | +0.51% | -9.71% | +4.94% |
Business Summary
Number of employees: 121
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene Therapeutics
100.0
%
| 0 | nan % | 4 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 4 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 22-12-11 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Romuald Corbau
CTO | Chief Tech/Sci/R&D Officer | 55 | Jan. 28 |
Peter Soparkar
COO | Chief Operating Officer | 53 | 19-10-29 |
R. Ramelmeier
CTO | Chief Tech/Sci/R&D Officer | 62 | 23-08-20 |
Anand Reddi
HRO | Human Resources Officer | 42 | - |
Star Seyedkazemi
PRN | Corporate Officer/Principal | 50 | 22-01-05 |
Corporate Officer/Principal | - | 20-06-24 | |
Dena House
HRO | Human Resources Officer | - | 19-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Whitcup
BRD | Director/Board Member | 64 | 20-04-15 |
Clarence Machado
CHM | Chairman | 60 | 17-03-13 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Jim Scopa
BRD | Director/Board Member | 65 | 19-04-30 |
C. Nicholson
BRD | Director/Board Member | 68 | Nov. 02 |
Mark Lupher
BRD | Director/Board Member | 53 | 19-04-30 |
Reed Tuckson
BRD | Director/Board Member | 73 | 21-02-18 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 20-12-08 |
Rabia Ozden
BRD | Director/Board Member | 56 | 22-03-16 |
Soo Hong
BRD | Director/Board Member | 52 | 22-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,756,850 | 20,386,246 ( 98.21 %) | 0 | 98.21 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.94% | 164M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.99% | 21.97B | |
-5.34% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- ADVM Stock
- Company Adverum Biotechnologies, Inc.